Zimmer Biomet Holdings Inc (NYSE:ZBH)
| 122.35 Delayed Data As of Oct 20 |  +0.47 / +0.39%Today’s Change | 95.63 Today|||52-Week Range 133.49 | +18.56% Year-to-Date |
Latest ZBH News | Press Releases
| NuVasive's TLX Interbody System Gets Expanded FDA Approval Oct 19 / Zacks.com - Paid Partner Content | Smith & Nephew: hippy hippy shake-up Oct 11 / FT.com - Paid Partner Content |
Today’s Trading
| Previous close | 121.88 |
| Today’s open | 122.37 |
| Day’s range | 121.32 - 122.83 |
| Volume | 792,749 |
| Average volume (3 months) | 1,351,807 |
| Market cap | $24.7B |
| Dividend yield | 0.78% |
Data as of 4:01pm ET, 10/20/2017
Growth & Valuation
| Earnings growth (last year) | +96.10% |
| Earnings growth (this year) | +3.52% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +28.11% |
| P/E ratio | 34.9 |
| Price/Sales | 2.72 |
| Price/Book | 2.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCRC R Bard Inc | +2.86 | +0.87% |
| TFXTeleflex Inc | +1.07 | +0.44% |
| BSXBoston Scientific Co... | +0.12 | +0.41% |
| ABMDAbiomed Inc | +2.41 | +1.40% |
Data as of 4:03pm ET, 10/20/2017
Financials
| Next reporting date | November 1, 2017 |
| EPS forecast (this quarter) | $1.75 |
| Annual revenue (last year) | $7.7B |
| Annual profit (last year) | $305.9M |
| Net profit margin | 3.98% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Director, Chief Executive & Financial Officer Daniel P. Florin |
Senior VP-Global Operations & Logistics Adrian Furey |
Corporate headquarters Warsaw, Indiana |
Forecasts
